A Phase III, Double-blind, Placebo-controlled, Multicenter, Randomized Study Of Pracinostat In Combination With Azacitidine In Patients ≥18 Years With Newly Diagnosed Acute Myeloid Leukemia Unfit For Standard Induction Chemotherapy -PRAN-16-52

IRB/UVA Tracking #
20410
Contact
Contact Phone
..
Phase
III
Primary purpose
Treatment
Cancer PI
Michael Keng
Status
OPEN TO ACCRUAL